BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1765436)

  • 1. Aliphatic and Olefinic Fat Suppression in the Orbit Using Polarity-altered Spectral and Spatial Selective Acquisition (PASTA) with Opposed Phase.
    Malis V; Bae WC; Yamamoto A; Kassai Y; McDonald MA; Miyazaki M
    Magn Reson Med Sci; 2024 Apr; 23(2):193-203. PubMed ID: 36948628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial Comment: Implementing Deep Learning to Extrapolate Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI.
    Arkoudis NA
    AJR Am J Roentgenol; 2023 Nov; 221(5):632. PubMed ID: 37466191
    [No Abstract]   [Full Text] [Related]  

  • 3. Texture Analysis for the Bone Age Assessment from MRI Images of Adolescent Wrists in Boys.
    Obuchowicz R; Nurzynska K; Pierzchala M; Piorkowski A; Strzelecki M
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical shift imaging: An indispensable tool in diagnosing musculoskeletal pathologies.
    Jahanvi V; Kelkar A
    SA J Radiol; 2021; 25(1):2061. PubMed ID: 34007477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance.
    Ozturk A; Grajo JR; Gee MS; Benjamin A; Zubajlo RE; Thomenius KE; Anthony BW; Samir AE; Dhyani M
    Ultrasound Med Biol; 2018 Dec; 44(12):2461-2475. PubMed ID: 30232020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis.
    Argo CK; Stine JG; Henry ZH; Lackner C; Patrie JT; Weltman AL; Caldwell SH
    Aliment Pharmacol Ther; 2018 Aug; 48(3):290-299. PubMed ID: 29797529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive quantification of hepatic fat content in healthy dogs by using proton magnetic resonance spectroscopy and dual gradient echo magnetic resonance imaging.
    Chicca FD; Schwarz A; Meier D; Grest P; Liesegang A; Kircher PR
    J Vet Sci; 2018 Jul; 19(4):570-576. PubMed ID: 29486536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat Quantification in the Abdomen.
    Hong CW; Fazeli Dehkordy S; Hooker JC; Hamilton G; Sirlin CB
    Top Magn Reson Imaging; 2017 Dec; 26(6):221-227. PubMed ID: 29176468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization.
    Luersen GF; Bhosale P; Szklaruk J
    J Hepatocell Carcinoma; 2015; 2():101-17. PubMed ID: 27508199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of liver fat fraction and iron with MRI and MR spectroscopy techniques.
    Sharma P; Altbach M; Galons JP; Kalb B; Martin DR
    Diagn Interv Radiol; 2014; 20(1):17-26. PubMed ID: 24047718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of hepatic ultrasound findings in subjects with magnetic resonance imaging defined hepatic steatosis following clinical islet transplantation: a case-control study.
    Jackson S; Mager DR; Bhargava R; Ackerman T; Imes S; Hubert G; Koh A; Shapiro AM; Senior PA
    Islets; 2013; 5(1):16-21. PubMed ID: 23514958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.
    Karlo CA; Donati OF; Burger IA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Eur Radiol; 2013 Jun; 23(6):1738-44. PubMed ID: 23300041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.
    Reeder SB; Hu HH; Sirlin CB
    J Magn Reson Imaging; 2012 Nov; 36(5):1011-4. PubMed ID: 22777847
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.
    Reeder SB; Cruite I; Hamilton G; Sirlin CB
    J Magn Reson Imaging; 2011 Oct; 34(4):729-749. PubMed ID: 22025886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of liver fat with magnetic resonance imaging.
    Reeder SB; Sirlin CB
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):337-57, ix. PubMed ID: 21094444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease.
    Hatta T; Fujinaga Y; Kadoya M; Ueda H; Murayama H; Kurozumi M; Ueda K; Komatsu M; Nagaya T; Joshita S; Kodama R; Tanaka E; Uehara T; Sano K; Tanaka N
    J Gastroenterol; 2010 Dec; 45(12):1263-71. PubMed ID: 20625773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fat quantification in humans: Evaluation by two-point water-fat imaging and localized proton spectroscopy.
    Liu CY; Redheuil A; Ouwerkerk R; Lima JA; Bluemke DA
    Magn Reson Med; 2010 Apr; 63(4):892-901. PubMed ID: 20373390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced MRI methods for assessment of chronic liver disease.
    Taouli B; Ehman RL; Reeder SB
    AJR Am J Roentgenol; 2009 Jul; 193(1):14-27. PubMed ID: 19542391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.
    Mitchell DG; Kim I; Chang TS; Vinitski S; Consigny PM; Saponaro SA; Ehrlich SM; Rifkin MD; Rubin R
    Invest Radiol; 1991 Dec; 26(12):1041-52. PubMed ID: 1765436
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.